| Treatments |
Before treatment |
After first treatment |
After second treatment |
| NSKE |
2.6 ± 1.15ab |
2.0 ± 1.73b |
1.66 ± 2.08b |
| CLE |
1.6 ± 0.57b |
1.3 ± 0.57b |
1.0 ± 1.00b |
| BLE |
1.3 ± 0.57b |
1.3 ± 0.57b |
1.0 ± 0.00b |
| NSKE+BLE |
1.3 ± 0.57b |
1.0 ± 1.00b |
0.6 ± 0.57b |
| CLE + BLE |
2.0 ± 1.00b |
1.6 ± 0.57b |
1.33 ± 0.57b |
| NSKE +CLE |
2.0 ± 1.00b |
1.0 ± 0.00b |
0.66 ± 0.57b |
| Diazinon 60% EC |
2.33 ± 0.57a |
0.3 ± 0.57c |
0.33 ± 0.57b |
| Control |
2.66 ± 0.57a |
3.6 ± 0.57a |
3.33 ± 0.57a |
Values are mean ± standard deviation of three replications. Similar alphabets within
the column was statistically not significant (p>0.05; LSD). |
